Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Successful Treatment of Carbapenem-Resistant Acinetobacter baumannii Meningitis With Sulbactam-Durlobactam

Clinical Infectious Diseases(2024)10.1093/cid/ciae210Source: DataRank Database

Successful Treatment of Carbapenem-Resistant Acinetobacter baumannii Meningitis With Sulbactam-Durlobactam is a research paper published in Clinical Infectious Diseases (2024). On theSindex it has a DataRank of 0. It has been cited 21 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access21 citations

Download PDF

Cite:

Linked data & code

bioproject

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 2.91)OA: greenTopics (62)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Shanan Immel ORCID,Sara M. Karaba ORCID,Caitlin Soto,Rick Conzemius ORCID,Emily Gisriel

Live enrichment

PubMed:38630890 PMC:PMC11478584 OpenAlex:https://openalex.org/W4394869006

National Institutes of Health

Grant: R21-AI173475

NIAID NIH HHS

Grant: R21 AI173475

FWCI

2.91

Citation Percentile

0.9%

Citation Trend

2024

2025

2026

greenLicense: https://academic.oup.com/pages/standard-publication-reuse-rights

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11478584/pdf/ciae210.pdf

publisherhttps://academic.oup.com/cid/advance-article-pdf/doi/10.1093/cid/ciae210/58162845/ciae210.pdf

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/11478584

journalhttps://doi.org/10.1093/cid/ciae210

Fields of Study

Antibiotic Resistance in BacteriaBacterial Infections and VaccinesAntibiotics Pharmacokinetics and EfficacyHumansAcinetobacter baumanniiFemaleSulbactamAdultAcinetobacter InfectionsAnti-Bacterial AgentsCarbapenemsMeningitis, BacterialMicrobial Sensitivity TestsWhole Genome Sequencingbeta-LactamasesCephalosporinsBacterial ProteinsDrug CombinationsTreatment OutcomeDrug Resistance, Multiple, BacterialAzabicyclo Compounds

MeSH Terms

Whole Genome SequencingAcinetobacter InfectionsAdultAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesCephalosporinsDrug CombinationsFemaleHumansMicrobial Sensitivity TestsSulbactamCarbapenemsTreatment OutcomeMeningitis, BacterialDrug Resistance, Multiple, BacterialAcinetobacter baumanniiAzabicyclo Compounds

Keywords

Acinetobacter baumanniiSulbactamBroth microdilutionMeropenemMedicineMicrobiologyPseudomonas aeruginosaSerial dilutionMeningitisCephalosporinBiologyAntimicrobialAntibioticsBacteriaMinimum inhibitory concentrationAntibiotic resistanceSurgeryPathologyImipenemAntimicrobial resistanceOxa-23Paradoxical EffectCefiderocol

Sustainable Development Goals

SDG 0: Good health and well-being

Successful Treatment of Carbapenem-Resistant Acinetobacter baumannii Meningitis With Sulbactam-Durlobactam

FAIR Checklist

Authors (11)

Funding (2 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)